EUCLID, 2016 trial summary

A randomised clinical trial investigating the effect of ticagrelor versus clopidogrel in

NCT01732822    N Engl J Med 2017;376:32-40  




Studied treatment
Control treatment



Patients
Group sizes -9 / -9



Blindness Inclusion period
Follow-up duration Centers
Lost to FU geographical localisation
Primary endpoint Design



EndpointX1N1X0N0TE95% CI Mortalité totale - -9 - -9 no data Mortalité vasculaire - -9 - -9 no data AVC fatal - -9 - -9 no data AVC non fatal - -9 - -9 no data IDM fatal - -9 - -9 no data IDM non fatal - -9 - -9 no data IDM totaux - -9 - -9 no data Evénements vasculaires - -9 - -9 no data Amputations - -9 - -9 no data augmentation de la distance de claudication initiale (m) - -9 - -9 no data augmentation de la distance de claudication absolue (m) - -9 - -9 no data Hémorragies fatales - -9 - -9 no data Hémorragies extra-crâniennes majeures - -9 - -9 no data effets secondaires - -9 - -9 no data0,22,01,0


Jones WS, Baumgartner I, Hiatt WR, Heizer G, Conte MS, White CJ, Berger JS, Held P, Katona BG, Mahaffey KW, Norgren L, Blomster J, Millegård M, Reist C, Patel MR, Fowkes GR Ticagrelor Compared With Clopidogrel in Patients with Prior Lower Extremity Revascularization for Peripheral Artery Disease. Circulation 2016 Nov 13;:     [PMID: 27840336]   link to pdf  

Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. N Engl J Med 2017;376:32-40     [PMID: 27959717]   link to pdf  



Registering number NCT01732822 (see trial on clinicaltrials.gov)
Code Name